✦ LIBER ✦

Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation

✍ Scribed by Hai Tran; Demetrios Petropoulos; Laura Worth; Craig A. Mullen; Timothy Madden; Borje Andersson; Mary Choroszy; John Nguyen; Susannah K. Webb; Ka Wah Chan

Book ID: 116277913
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 125 KB
Volume: 10
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2004.07.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Individualizing high-dose oral busulfan:

Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies

✍ Choroszy, M; Danielson, M; Przepiorka, D; Chan, K-W; Tran, H T; Madden, T; Petro 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 87 KB

Unpredictability of Intravenous Busulfan

Unpredictability of Intravenous Busulfan Pharmacokinetics in Children Undergoing Hematopoietic Stem Cell Transplantation for Advanced Beta Thalassemia: Limited Toxicity with a Dose-Adjustment Policy

✍ Robert Chiesa; Barbara Cappelli; Roberto Crocchiolo; Ilaria Frugnoli; Erika Bira 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 310 KB

Dose modification protocol using intrave

Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies

✍ Casey B. Williams; Suzanne D. Day; Michael D. Reed; Edward A. Copelan; Thomas Be 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Evaluation of safety and pharmacokinetic

Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantation

✍ Hugo F Fernandez; Hai T Tran; Federico Albrecht; Shari Lennon; Humberto Caldera; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 125 KB

273: Safety and efficacy of high-dose bu

273: Safety and efficacy of high-dose busulfan by 90-hour continuous infusion in hematologic malignancy patients undergoing allogeneic stem cell transplants

✍ T. Shea; C. Walko; J. Serody; D. Gabriel; T. Comeau; K. Rao; A. Ivanova; A. Shar 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Once-Daily Intravenous Busulfan with The

Once-Daily Intravenous Busulfan with Therapeutic Drug Monitoring Compared to Conventional Oral Busulfan Improves Survival and Engraftment in Children Undergoing Allogeneic Stem Cell Transplantation

✍ Imke H. Bartelink; Robbert G.M. Bredius; Tessa T. Ververs; Martine F. Raphael; C 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 293 KB